STERIS plc (STE)
USD 207.01
(-1.19%)
USD 207.01
(-1.19%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 1.4 Billion USD | -1.31% |
| 2023 | 1.4 Billion USD | -11.96% |
| 2022 | 1.59 Billion USD | 99.42% |
| 2021 | 797.64 Million USD | 1.96% |
| 2020 | 782.27 Million USD | 6.73% |
| 2019 | 732.97 Million USD | 6.13% |
| 2018 | 690.66 Million USD | -6.6% |
| 2017 | 739.46 Million USD | 8.21% |
| 2016 | 683.37 Million USD | 24.82% |
| 2015 | 547.48 Million USD | 27.44% |
| 2014 | 429.61 Million USD | 8.55% |
| 2013 | 395.78 Million USD | 14.55% |
| 2012 | 345.5 Million USD | -3.96% |
| 2011 | 359.74 Million USD | 8.81% |
| 2010 | 330.62 Million USD | -4.92% |
| 2009 | 347.74 Million USD | -9.67% |
| 2008 | 384.95 Million USD | 6.78% |
| 2007 | 360.52 Million USD | 3.25% |
| 2006 | 349.17 Million USD | 6.89% |
| 2005 | 326.65 Million USD | 2.87% |
| 2004 | 317.54 Million USD | 12.19% |
| 2003 | 283.05 Million USD | 3.08% |
| 2002 | 274.58 Million USD | -9.61% |
| 2001 | 303.76 Million USD | -6.65% |
| 2000 | 325.39 Million USD | 22.56% |
| 1999 | 265.5 Million USD | 25.27% |
| 1998 | 211.94 Million USD | 29.23% |
| 1997 | 164 Million USD | 322.68% |
| 1996 | 38.8 Million USD | 36.14% |
| 1995 | 28.5 Million USD | 38.35% |
| 1994 | 20.6 Million USD | 50.36% |
| 1993 | 13.7 Million USD | 87.67% |
| 1992 | 7.3 Million USD | 40.38% |
| 1991 | 5.2 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 407.69 Million USD | 6.02% |
| 2024 FY | 1.32 Billion USD | -5.13% |
| 2024 Q3 | 386.43 Million USD | -5.22% |
| 2024 Q4 | 404.28 Million USD | 4.62% |
| 2024 Q1 | 384.56 Million USD | 6.14% |
| 2023 FY | 1.4 Billion USD | -11.96% |
| 2023 Q2 | 348.12 Million USD | -3.13% |
| 2023 Q1 | 359.37 Million USD | -25.09% |
| 2023 Q3 | 330.65 Million USD | -5.02% |
| 2023 Q4 | 362.3 Million USD | 9.57% |
| 2022 Q1 | 411.94 Million USD | 72.66% |
| 2022 FY | 1.59 Billion USD | 99.42% |
| 2022 Q2 | 363.63 Million USD | -11.73% |
| 2022 Q3 | 335.38 Million USD | -7.77% |
| 2022 Q4 | 479.73 Million USD | 43.04% |
| 2021 FY | 797.64 Million USD | 1.96% |
| 2021 Q4 | 238.58 Million USD | 20.01% |
| 2021 Q1 | 171.4 Million USD | -16.91% |
| 2021 Q3 | 198.81 Million USD | 5.27% |
| 2021 Q2 | 188.85 Million USD | 10.18% |
| 2020 FY | 782.27 Million USD | 6.73% |
| 2020 Q2 | 192.2 Million USD | -1.11% |
| 2020 Q3 | 189.41 Million USD | -1.45% |
| 2020 Q4 | 206.28 Million USD | 8.91% |
| 2020 Q1 | 194.36 Million USD | 2.84% |
| 2019 Q4 | 188.99 Million USD | -1.19% |
| 2019 Q3 | 191.26 Million USD | 7.4% |
| 2019 Q2 | 178.08 Million USD | 1.98% |
| 2019 FY | 732.97 Million USD | 6.13% |
| 2019 Q1 | 174.62 Million USD | -2.54% |
| 2018 Q4 | 179.18 Million USD | 2.78% |
| 2018 FY | 690.66 Million USD | -6.6% |
| 2018 Q3 | 174.33 Million USD | 4.19% |
| 2018 Q2 | 167.33 Million USD | -1.46% |
| 2018 Q1 | 169.81 Million USD | -23.34% |
| 2017 Q3 | 173.35 Million USD | -2.77% |
| 2017 FY | 739.46 Million USD | 8.21% |
| 2017 Q1 | 166.31 Million USD | 1.16% |
| 2017 Q2 | 178.29 Million USD | 7.21% |
| 2017 Q4 | 221.5 Million USD | 27.78% |
| 2016 Q1 | 140.6 Million USD | -3.15% |
| 2016 Q2 | 186.71 Million USD | 32.8% |
| 2016 Q3 | 191.65 Million USD | 2.65% |
| 2016 Q4 | 164.4 Million USD | -14.22% |
| 2016 FY | 683.37 Million USD | 24.82% |
| 2015 FY | 547.48 Million USD | 27.44% |
| 2015 Q2 | 139.29 Million USD | 10.47% |
| 2015 Q1 | 126.09 Million USD | 12.02% |
| 2015 Q3 | 136.91 Million USD | -1.71% |
| 2015 Q4 | 145.16 Million USD | 6.02% |
| 2014 Q3 | 107.07 Million USD | 2.77% |
| 2014 Q4 | 112.56 Million USD | 5.12% |
| 2014 FY | 429.61 Million USD | 8.55% |
| 2014 Q1 | 105.78 Million USD | -6.91% |
| 2014 Q2 | 104.18 Million USD | -1.51% |
| 2013 Q3 | 102.16 Million USD | 12.41% |
| 2013 Q4 | 113.63 Million USD | 11.22% |
| 2013 FY | 395.78 Million USD | 14.55% |
| 2013 Q1 | 89.08 Million USD | -2.16% |
| 2013 Q2 | 90.89 Million USD | 2.03% |
| 2012 Q4 | 91.05 Million USD | 9.55% |
| 2012 Q1 | 85.76 Million USD | -12.28% |
| 2012 Q3 | 83.11 Million USD | -2.86% |
| 2012 FY | 345.5 Million USD | -3.96% |
| 2012 Q2 | 85.56 Million USD | -0.23% |
| 2011 Q4 | 97.77 Million USD | 20.1% |
| 2011 Q1 | 80.72 Million USD | -5.79% |
| 2011 Q2 | 80.04 Million USD | -0.85% |
| 2011 Q3 | 81.41 Million USD | 1.71% |
| 2011 FY | 359.74 Million USD | 8.81% |
| 2010 Q3 | 80.04 Million USD | -3.22% |
| 2010 FY | 330.62 Million USD | -4.92% |
| 2010 Q2 | 82.7 Million USD | 0.63% |
| 2010 Q4 | 85.68 Million USD | 7.06% |
| 2010 Q1 | 82.18 Million USD | -10.05% |
| 2009 FY | 347.74 Million USD | -9.67% |
| 2009 Q1 | 95.62 Million USD | -1.3% |
| 2009 Q4 | 91.36 Million USD | 21.18% |
| 2009 Q3 | 75.39 Million USD | -11.67% |
| 2009 Q2 | 85.35 Million USD | -10.74% |
| 2008 Q4 | 96.88 Million USD | 1.15% |
| 2008 FY | 384.95 Million USD | 6.78% |
| 2008 Q2 | 96.52 Million USD | 0.8% |
| 2008 Q1 | 95.75 Million USD | 4.11% |
| 2008 Q3 | 95.78 Million USD | -0.77% |
| 2007 Q2 | 25.37 Million USD | -70.77% |
| 2007 Q3 | 90.67 Million USD | 257.31% |
| 2007 Q4 | 91.97 Million USD | 1.44% |
| 2007 FY | 360.52 Million USD | 3.25% |
| 2007 Q1 | 86.8 Million USD | -2.92% |
| 2006 Q4 | 89.41 Million USD | 7.68% |
| 2006 Q2 | 89.18 Million USD | -1.47% |
| 2006 Q1 | 90.52 Million USD | 7.11% |
| 2006 Q3 | 83.04 Million USD | -6.89% |
| 2006 FY | 349.17 Million USD | 6.89% |
| 2005 Q2 | -19.37 Million USD | -123.67% |
| 2005 Q3 | 79.65 Million USD | 511.01% |
| 2005 FY | 326.65 Million USD | 2.87% |
| 2005 Q4 | 84.51 Million USD | 6.1% |
| 2005 Q1 | 81.87 Million USD | 0.3% |
| 2004 Q1 | 80.34 Million USD | 7.55% |
| 2004 Q3 | 77.27 Million USD | -1.3% |
| 2004 Q2 | 78.29 Million USD | -2.56% |
| 2004 Q4 | 81.63 Million USD | 5.65% |
| 2004 FY | 317.54 Million USD | 12.19% |
| 2003 Q2 | 67.21 Million USD | -5.63% |
| 2003 Q3 | 69.91 Million USD | 4.02% |
| 2003 FY | 283.05 Million USD | 3.08% |
| 2003 Q1 | 71.22 Million USD | 1.43% |
| 2003 Q4 | 74.7 Million USD | 6.85% |
| 2002 Q3 | 65.33 Million USD | -3.84% |
| 2002 Q1 | 71.09 Million USD | 20.91% |
| 2002 FY | 274.58 Million USD | -9.61% |
| 2002 Q4 | 70.21 Million USD | 7.47% |
| 2002 Q2 | 67.94 Million USD | -4.43% |
| 2001 Q2 | 80.38 Million USD | -3.87% |
| 2001 FY | 303.76 Million USD | -6.65% |
| 2001 Q4 | 58.8 Million USD | -27.38% |
| 2001 Q1 | 83.61 Million USD | -16.63% |
| 2001 Q3 | 80.96 Million USD | 0.73% |
| 2000 Q4 | 100.29 Million USD | 30.25% |
| 2000 FY | 325.39 Million USD | 22.56% |
| 2000 Q3 | 77 Million USD | 3.49% |
| 2000 Q2 | 74.4 Million USD | 0.81% |
| 2000 Q1 | 73.8 Million USD | -0.67% |
| 1999 Q4 | 74.3 Million USD | 16.64% |
| 1999 FY | 265.5 Million USD | 25.27% |
| 1999 Q1 | 55.56 Million USD | -7.72% |
| 1999 Q2 | 64.9 Million USD | 16.81% |
| 1999 Q3 | 63.7 Million USD | -1.85% |
| 1998 Q3 | 52.08 Million USD | -0.87% |
| 1998 FY | 211.94 Million USD | 29.23% |
| 1998 Q1 | 47.09 Million USD | -8.19% |
| 1998 Q2 | 52.54 Million USD | 11.57% |
| 1998 Q4 | 60.21 Million USD | 15.59% |
| 1997 Q3 | 41.6 Million USD | 12.43% |
| 1997 Q1 | 34.1 Million USD | 224.76% |
| 1997 FY | 164 Million USD | 322.68% |
| 1997 Q4 | 51.3 Million USD | 23.32% |
| 1997 Q2 | 37 Million USD | 8.5% |
| 1996 Q2 | 9.2 Million USD | 2.22% |
| 1996 FY | 38.8 Million USD | 36.14% |
| 1996 Q4 | 10.5 Million USD | 5.0% |
| 1996 Q3 | 10 Million USD | 8.7% |
| 1996 Q1 | 9 Million USD | 3.45% |
| 1995 Q2 | 6.7 Million USD | 15.52% |
| 1995 Q3 | 7.2 Million USD | 7.46% |
| 1995 Q4 | 8.7 Million USD | 20.83% |
| 1995 FY | 28.5 Million USD | 38.35% |
| 1995 Q1 | 5.8 Million USD | -9.38% |
| 1994 Q2 | 4.7 Million USD | 17.5% |
| 1994 Q4 | 6.4 Million USD | 16.36% |
| 1994 Q3 | 5.5 Million USD | 17.02% |
| 1994 Q1 | 4 Million USD | -4.76% |
| 1994 FY | 20.6 Million USD | 50.36% |
| 1993 Q1 | 2.8 Million USD | 121.71% |
| 1993 FY | 13.7 Million USD | 87.67% |
| 1993 Q2 | 3.3 Million USD | 17.86% |
| 1993 Q3 | 3.4 Million USD | 3.03% |
| 1993 Q4 | 4.2 Million USD | 23.53% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q4 | -12.9 Million USD | 0.0% |
| 1992 FY | 7.3 Million USD | 40.38% |
| 1992 Q1 | - USD | 100.0% |
| 1992 Q3 | - USD | 0.0% |
| 1991 FY | 5.2 Million USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q4 | -8.6 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Abbott Laboratories | 15.71 Billion USD | 91.087% |
| Allurion Technologies Inc. | 120.57 Million USD | -1061.403% |
| Artivion, Inc. | 223.43 Million USD | -526.745% |
| Avanos Medical, Inc. | 375.5 Million USD | -272.933% |
| Butterfly Network, Inc. | 162.46 Million USD | -761.942% |
| Butterfly Network, Inc. | 162.46 Million USD | -761.942% |
| Bio-Rad Laboratories, Inc. | 1.04 Billion USD | -33.68% |
| Boston Scientific Corporation | 7.47 Billion USD | 81.274% |
| Perspective Therapeutics, Inc. | 17.42 Million USD | -7936.05% |
| CONMED Corporation | 564.24 Million USD | -148.185% |
| Edwards Lifesciences Corporation | 3.09 Billion USD | 54.694% |
| Paragon 28, Inc. | 210.1 Million USD | -566.522% |
| Glaukos Corporation | 367.83 Million USD | -280.703% |
| Globus Medical, Inc. | 887.16 Million USD | -57.848% |
| Inspire Medical Systems, Inc. | 568.49 Million USD | -146.328% |
| Integer Holdings Corporation | 250.95 Million USD | -458.004% |
| Medtronic plc | 16.12 Billion USD | 91.318% |
| Nevro Corp. | 389.36 Million USD | -259.65% |
| Owlet, Inc. | 51.21 Million USD | -2634.067% |
| Penumbra, Inc. | 590.87 Million USD | -136.997% |
| Vicarious Surgical Inc. | 80.66 Million USD | -1636.0% |
| Smith & Nephew plc | 3.46 Billion USD | 59.609% |
| Sonendo, Inc. | 68.46 Million USD | -1945.369% |
| Stryker Corporation | 9.2 Billion USD | 84.794% |
| Vapotherm, Inc. | 66.02 Million USD | -2020.957% |
| Zimmer Biomet Holdings, Inc. | 3.27 Billion USD | 57.254% |